JHS Svendgaard Laboratories Stock Screener | Share Price & Fundamental Analysis
JHS
Personal Care
Share Price NSE
₹9.20
▲
0.32 (3.60%)
Share Price BSE
₹9.50
▲
0.14 (1.50%)
As of April 15, 2026, the JHS Svendgaard Laboratories share price (NSE: JHS) is ₹9.20 on NSE and ₹9.50 on BSE, up 3.60% from the previous close, with shares trading between ₹8.86 and ₹9.59, and a 52-week range of ₹6.55–₹15.85.
Browse JHS income statement to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
JHS Svendgaard Laboratories Market Cap
₹78.33 Cr.
JHS P/E Ratio (TTM)
-14.05
JHS Svendgaard Laboratories P/B Ratio
0.42
EPS (TTM)
₹-2.37
Dividend Yield
-
Debt to Equity
0.03
JHS 52 Week High
₹15.85
JHS Svendgaard Laboratories 52 Week Low
₹6.55
Operating Margin
7.00%
Profit Margin
4.17%
JHS Revenue (TTM)
₹24.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹201.00
Total Equity
₹173.00
JHS Svendgaard Laboratories Share Price History - Stock Screener Chart
Screen JHS historical share price movements with interactive charts. Analyze price trends and patterns.
JHS Svendgaard Laboratories Company Profile - Fundamental Screener
Screen JHS Svendgaard Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JHS shares.
Sector
Consumer Goods
Industry
Personal Care
Sub-Sector
Personal Care
Segment
E
ISIN
INE544H01014
JHS Svendgaard Laboratories Balance Sheet Screener
Screen JHS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 201 | 197 | 228 | 222 | 228 | 241 | 221 | 208 | 155 | 121 |
| Current Assets | 54 | 44 | 85 | 79 | 121 | 130 | 102 | 103 | 43 | 36 |
| Fixed Assets | 90 | 90 | 65 | 59 | 63 | 66 | 71 | 71 | 65 | 65 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 4 | 18 | 8 | 7 | 8 | 2 | 2 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 173 | 170 | 174 | 195 | 198 | 185 | 181 | 174 | 134 | 101 |
| Share Capital | 86 | 78 | 78 | 65 | 64 | 61 | 61 | 61 | 44 | 38 |
| Reserves & Surplus | 85 | 92 | 95 | 121 | 124 | 117 | 116 | 113 | 86 | 57 |
JHS Svendgaard Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen JHS Svendgaard Laboratories income statement and profit fundamentals.
Analyze JHS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for JHS Svendgaard Laboratories share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 23 | 25 | 27 | 23 | 21 | 25 | 23 | 17 | 19 | 16 | 29 | 23 | 24 | 23 |
| Expenses | 22 | 21 | 22 | 33 | 22 | 21 | 23 | 21 | 14 | 19 | 18 | 44 | 24 | 23 | 23 |
| EBITDA | 2 | 2 | 3 | -7 | 1 | 0 | 2 | 2 | 2 | 1 | -2 | -15 | -1 | 1 | 0 |
| Operating Profit % | 7.00% | 4.00% | 7.00% | -33.00% | 1.00% | -4.00% | 8.00% | 4.00% | 0.00% | 2.00% | -13.00% | -102.00% | -10.00% | -9.00% | -7.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | 0 | 0 | 1 | -9 | -2 | -2 | 0 | 0 | 1 | -1 | -3 | -17 | -3 | -1 | -2 |
| Tax | -1 | 0 | 0 | -2 | 0 | 8 | 1 | 1 | 1 | 0 | -1 | -6 | 0 | 0 | 2 |
| Net Profit | 1 | 0 | 1 | -7 | -2 | -10 | -1 | -1 | 0 | -1 | -3 | -11 | -3 | -1 | -4 |
| EPS | 0.09 | -0.02 | 0.12 | -0.84 | -0.21 | -1.24 | -0.08 | -0.10 | 0.00 | -0.09 | -0.33 | -1.37 | -0.24 | -0.11 | -0.59 |
JHS Svendgaard Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen JHS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -5 | -9 | 23 | -9 | 12 | 10 | -11 | 14 | -4 | -4 |
| Investing Activities | -20 | -21 | 10 | -5 | -2 | -11 | -7 | -27 | -3 | 2 |
| Financing Activities | 23 | 2 | -1 | -2 | 10 | 1 | 13 | 14 | 10 | 4 |
| Net Cash Flow | -2 | -28 | 32 | -16 | 20 | 0 | -5 | 0 | 3 | 2 |
JHS Svendgaard Laboratories Shareholding Pattern Screener
See JHS Svendgaard Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check JHS Svendgaard Laboratories promoter holding and ownership changes for JHS on TickJournal.
| Item | 2026-Feb | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Aug |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 33.85% | 34.56% | 34.56% | 34.56% | 34.56% | 34.56% | 34.56% | 34.56% |
| FII Holding | 3.60% | 1.57% | 1.57% | 1.59% | 1.60% | 1.59% | 1.69% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.84% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 46.63% | 47.59% | 47.30% | 47.00% | 46.91% | 47.05% | 46.53% | 42.06% |
| Other Holding | 15.93% | 16.29% | 16.57% | 16.85% | 16.93% | 16.80% | 17.22% | 19.55% |
| Shareholder Count | 25,377 | 25,151 | 25,007 | 25,155 | 25,567 | 26,276 | 25,994 | 25,591 |
JHS Svendgaard Laboratories Share Dividend Screener - Share Yield Analysis
Check JHS Svendgaard Laboratories dividend history with payout and yield data.
View JHS Svendgaard Laboratories dividend details including ex-dates and amounts for JHS stock.
JHS Svendgaard Laboratories Stock Index Membership
See which indices include JHS Svendgaard Laboratories stock.
Check JHS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
JHS Svendgaard Laboratories Market Events Screener - Corporate Actions
Get JHS Svendgaard Laboratories corporate actions including splits, bonuses, and buybacks.
Check JHS Svendgaard Laboratories stock events that may affect JHS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 37.29% | ||
| Annual General Meeting | NA | 6.07% | ||
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | -1.42% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -7.53% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 2.70% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -0.50% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -6.08% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -7.49% |
| 2024-07-04 | 2024-07-04 | Extraordinary General Meeting | NA | 7.82% |
JHS Svendgaard Laboratories Competitors Screener - Peer Comparison
Screen JHS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Godrej Consumer Products | 110,316 | 59.71 | 14,680 | 2.19% | 1,852 | 52.72 |
| Dabur India | 77,280 | 41.85 | 13,113 | 1.76% | 1,740 | 44.48 |
| Colgate Palmolive | 52,741 | 39.11 | 6,179 | 7.33% | 1,437 | 48.10 |
| P&G Hygiene and Health Care | 31,773 | 36.56 | 3,412 | -19.87% | 637 | 40.42 |
| Gillette | 25,104 | 39.96 | 2,263 | -14.91% | 418 | 45.41 |
| Emami | 18,514 | 23.00 | 3,877 | 6.96% | 803 | 49.59 |
| Cupid | 12,604 | 149.16 | 203 | 13.97% | 41 | 65.47 |
| Mamaearth | 11,220 | 69.36 | 2,146 | 8.94% | 73 | 74.87 |
| Bajaj Consumer Care | 5,646 | 32.57 | 1,000 | -2.76% | 125 | 72.17 |
| Anondita Medicare | 1,483 | 93.39 | 77 | % | 16 | 59.82 |
JHS Svendgaard Laboratories Company Announcements - News Screener
Screen JHS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-19 | Closure of Trading Window | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-10 | Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulation 2015 For The Quarter Ended December 31 2025 | - |
| 2026-02-10 | Appointment Of Internal Auditors | - |
| 2026-02-10 | Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Nine Month Ended 31St December 2025 | - |
| 2026-02-10 | Un- Audited Financial Result For The Quarter Ended 31St December 2025 | - |
| 2026-02-10 | Intimation Of Grant Of ESOP | - |
| 2026-02-04 | Board Meeting Intimation for The Un-Audited Financial Statement For Quarter And Nine Months Ended 31 December 2025. | - |
| 2026-02-01 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-26 | Closure of Trading Window | - |
| 2025-12-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2025-11-14 | Financial Results For The Quarter And Half Year Ended 30Th September 2025 | - |
| 2025-11-14 | Intimation Of Grant Of ESOP | - |
| 2025-11-10 | Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025. | - |
| 2025-11-07 | Board Meeting Intimation for The Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025. | - |
| 2025-10-15 | INTIMATION OF WARNING LETTER ISSUED BY THE STOCK EXCHANGES. | - |